184 related articles for article (PubMed ID: 22997913)
41. Left-ventricular hypertrophy and renal outcome in hypertensive patients in primary-care.
Ravera M; Noberasco G; Signori A; Re M; Filippi A; Cannavò R; Weiss U; Cricelli C; Deferrari G; Paoletti E
Am J Hypertens; 2013 May; 26(5):700-7. PubMed ID: 23391620
[TBL] [Abstract][Full Text] [Related]
42. Signal averaged ECG in different patterns of left ventricular hypertrophy and geometry in hypertension.
Wojszwiłło A; Łoboz-Grudzień K; Jaroch J
Kardiol Pol; 2003 May; 58(5):335-43. PubMed ID: 14523481
[TBL] [Abstract][Full Text] [Related]
43. [Role of free radical oxidation in the development of cardiovascular events in chronic renal failure].
Dzgoeva FU; Gatagonova TM; Dzugkoeva FS; Kochisova ZKh; Kadzaeva ZK; Khamitsaeva OV
Ter Arkh; 2010; 82(1):51-6. PubMed ID: 20364702
[TBL] [Abstract][Full Text] [Related]
44. The prevalence of reduced glomerular filtration rate in older hypertensive patients and its association with cardiovascular disease: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial.
Rahman M; Brown CD; Coresh J; Davis BR; Eckfeldt JH; Kopyt N; Levey AS; Nwachuku C; Pressel S; Reisin E; Walworth C;
Arch Intern Med; 2004 May; 164(9):969-76. PubMed ID: 15136305
[TBL] [Abstract][Full Text] [Related]
45. Association of Left Ventricular Hypertrophy With a Faster Rate of Renal Function Decline in Elderly Patients With Non-End-Stage Renal Disease.
Shi HT; Wang XJ; Li J; Song GF; Huang ZY; Guo XY; Guo JJ; Lv ZY; Li HW; Ge JB; Cui J; Qi GM
J Am Heart Assoc; 2015 Nov; 4(11):. PubMed ID: 26553212
[TBL] [Abstract][Full Text] [Related]
46. Persistence of left ventricular hypertrophy is a stronger indicator of cardiovascular events than baseline left ventricular mass or systolic performance: 10 years of follow-up.
Muiesan ML; Salvetti M; Rizzoni D; Monteduro C; Castellano M; Agabiti-Rosei E
J Hypertens Suppl; 1996 Dec; 14(5):S43-9. PubMed ID: 9120684
[TBL] [Abstract][Full Text] [Related]
47. Reduction of left ventricular mass index with blood pressure reduction in chronic renal failure.
Tucker B; Fabbian F; Giles M; Johnston A; Baker LR
Clin Nephrol; 1999 Dec; 52(6):377-82. PubMed ID: 10604646
[TBL] [Abstract][Full Text] [Related]
48. Post-operative acute kidney injury in patients with renal cell carcinoma is a potent risk factor for new-onset chronic kidney disease after radical nephrectomy.
Cho A; Lee JE; Kwon GY; Huh W; Lee HM; Kim YG; Kim DJ; Oh HY; Choi HY
Nephrol Dial Transplant; 2011 Nov; 26(11):3496-501. PubMed ID: 21406544
[TBL] [Abstract][Full Text] [Related]
49. Left ventricular hypertrophy versus chronic kidney disease as predictors of cardiovascular events in hypertension: a Greek 6-year-follow-up study.
Tsioufis C; Vezali E; Tsiachris D; Dimitriadis K; Taxiarchou E; Chatzis D; Thomopoulos C; Syrseloudis D; Stefanadi E; Mihas C; Katsi V; Papademetriou V; Stefanadis C
J Hypertens; 2009 Apr; 27(4):744-52. PubMed ID: 19516174
[TBL] [Abstract][Full Text] [Related]
50. Left ventricular hypertrophy in chronic kidney disease: A diagnostic criteria comparison.
Nardi E; Mulè G; Giammanco A; Mattina A; Geraci G; Nardi C; Averna M
Nutr Metab Cardiovasc Dis; 2021 Jan; 31(1):137-144. PubMed ID: 33092976
[TBL] [Abstract][Full Text] [Related]
51. Increased rho kinase activity in mononuclear cells of dialysis and stage 3-4 chronic kidney disease patients with left ventricular hypertrophy: Cardiovascular risk implications.
Calò LA; Vertolli U; Pagnin E; Ravarotto V; Davis PA; Lupia M; Naso E; Maiolino G; Naso A
Life Sci; 2016 Mar; 148():80-5. PubMed ID: 26872982
[TBL] [Abstract][Full Text] [Related]
52. [Cystatin C is a new marker for left ventricular hypertrophy in patients with chronic kidney disease].
Vasilyeva MP; Rudenko TE; Kutyrina IM; Solomakhina NI
Ter Arkh; 2015; 87(6):17-22. PubMed ID: 26281190
[TBL] [Abstract][Full Text] [Related]
53. Eccentric Left Ventricular Hypertrophy and Sudden Death in Patients with End-Stage Kidney Disease.
de Roij van Zuijdewijn CL; Hansildaar R; Bots ML; Blankestijn PJ; van den Dorpel MA; Grooteman MP; Kamp O; ter Wee PM; Nubé MJ
Am J Nephrol; 2015; 42(2):126-33. PubMed ID: 26382055
[TBL] [Abstract][Full Text] [Related]
54. Progression of left ventricular hypertrophy in children with early chronic kidney disease: 2-year follow-up study.
Mitsnefes MM; Kimball TR; Kartal J; Witt SA; Glascock BJ; Khoury PR; Daniels SR
J Pediatr; 2006 Nov; 149(5):671-5. PubMed ID: 17095341
[TBL] [Abstract][Full Text] [Related]
55. [Specific features of cognitive impairments in patients with predialysis chronic kidney disease].
Rogova IV; Fomin VV; Damulin IV; Shashkova EV
Ter Arkh; 2013; 85(6):25-30. PubMed ID: 23866595
[TBL] [Abstract][Full Text] [Related]
56. Risk factors for increased left ventricular hypertrophy in patients with chronic kidney disease.
Nitta K; Iimuro S; Imai E; Matsuo S; Makino H; Akizawa T; Watanabe T; Ohashi Y; Hishida A
Clin Exp Nephrol; 2013 Oct; 17(5):730-742. PubMed ID: 23318981
[TBL] [Abstract][Full Text] [Related]
57. Subclinical nephrosclerosis is linked to left ventricular hypertrophy independent of classical atherogenic factors.
Haruyama N; Tsuchimoto A; Masutani K; Nagata M; Kitada H; Tanaka M; Tsuruya K; Kitazono T
Hypertens Res; 2014 May; 37(5):472-7. PubMed ID: 24305517
[TBL] [Abstract][Full Text] [Related]
58. Left ventricular hypertrophy and progression of chronic kidney disease.
Paoletti E
J Nephrol; 2012; 25(6):847-50. PubMed ID: 22460180
[TBL] [Abstract][Full Text] [Related]
59. Effects of insulin resistance on left ventricular hypertrophy in patients with CKD stage 1-3.
Wang CJ; Bao XR; Du GW; Wang Y; Chen K; Shen ML; Wang LZ
Int Urol Nephrol; 2014 Aug; 46(8):1609-17. PubMed ID: 24839054
[TBL] [Abstract][Full Text] [Related]
60. Retinopathy and left ventricular hypertrophy in patients with chronic kidney disease: Interrelationship and impact on clinical outcomes.
Kim Y; Cho JS; Cho WK; Yoon HE; Hong YA; Chang YK; Yang CW; Kim SY; Hwang HS
Int J Cardiol; 2017 Dec; 249():372-376. PubMed ID: 29121742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
